Peter B. Illei, MD
Cytopathology
Highlights
Johns Hopkins Affiliations:
- Johns Hopkins School of Medicine Faculty
About Peter B. Illei
Primary Academic Title
Associate Professor of Pathology
Background
Dr. Peter Bela Illei is an associate professor of pathology in the Division of Cytopathology at the Johns Hopkins University School of Medicine. His areas of clinical expertise include pulmonary pathology, transplant pathology, cytopathology and lung cancer biomarkers.
Dr. Illei earned his medical degree from University of Pécs School of Medicine. He completed his residency at New York University Medical Center in pathology and performed a fellowship in oncologic pathology and cytopathology at Memorial Sloan Kettering Cancer Center.
Dr. Illei’s research interests include development of novel immunohistochemical and molecular markers for the diagnosis of solid tissue tumors, pathology of lung cancer and mesothelioma, as well as lung transplantation.
Centers and Institutes
Additional Academic Titles
Associate Professor of Oncology
Research Interests
Development of biomarkers for thoracic neoplasms., pathology of lung transplantation, Pathology of thoracic diseases
Research Summary
Dr. Illei’s research focuses on the immunohistochemical and molecular characterization of lung cancers and mesothelioma.
Selected Publications
Illei PB, Belchis D, Tseng LH, Nguyen D, De Marchi F, Haly L, Riel S, Beierl K, Zheng G, Brahmer JR, Askin FB, Gocke CD, Eshleman JR, Forde PM and Ling MT. Clinical mutational profiling of 1006 lung cancers by next generation sequencing. Oncotarget. 5/20/2017 [Epub ahead of print].
Illei PB, Rusch V, Zakowski MF, Ladanyi M: Homozygous Deletion of CDKN2A and Co-Deletion of the Methylthioadenosine Phosphorylase Gene in the Majority of Pleural Mesotheliomas. Clin Can Res. 2003 Jun;9(6):2108-13.
Illei PB, Wong W, Wu N, Chu L, Gupta R, Schulze K, Gubens MA. ALK Testing Trends and Patterns Among Community Practices in the United States. JCO Precision Oncol. Epub Oct. 8, 2018.
Bishop JA, Sharma R, Illei PB. Napsin A and thyroid transcription factor-1 expression in carcinomas of the lung, breast, pancreas, colon, kidney, thyroid, and malignant mesothelioma. Hum Pathol. 2010 Jan;41(1):20-5. Epub 2009 Sep 8.
Xing D, Banet N, Sharma R, Vang R, Ronnett BM, Illei PB. Aberrant Pax-8 expression in well-differentiated papillary mesothelioma and malignant mesothelioma of the peritoneum: a clinicopathologic study. Hum Pathol. 2017 Dec 11. [Epub ahead of print]
Honors
- Pulmonary Pathology Society First Prize, United States and Canadian Academy of Pathology, 1/1/02
- Poster Award, International Congress of the International Academy of Pathology, 1/1/96
- First Prize Young Clinical Investigator, Postgraduate Medical School, 1/1/90
Memberships
- International Association for the Study of Lung Cancer (IASLC)
- Pulmonary Pathology Society (PPS)
- US-Canadian Academy of Pathology (USCAP)
- American Society of Cytopathology (ASC)
- American Society of Clinical Oncology
Locations
- The Johns Hopkins Hospital
- 1800 Orleans Street, Baltimore, MD 21287
- phone: 410-955-5000
- fax: 410-955-5001
Expertise
Education
Memorial Sloan Kettering Cancer Center
Fellowship, Oncologic Surgical Pathology, 2000Memorial Sloan Kettering Cancer Center
Fellowship, Cytopathology, 1999NYU Langone Hospital
Residency, Pathology - Anatomic & Clinical, 1998University of Pecs Medical School
Medical Education, MD, 1988Board Certifications
Cytopathology
American Board of Pathology, 2001Anatomic Pathology
American Board of Pathology, 2000Insurance
- Aetna
- CareFirst
- Cigna
- First Health
- Geisinger Health Plan
- HealthSmart/Accel
- Humana
- Johns Hopkins Health Plans
- MultiPlan
- Pennsylvania's Preferred Health Networks (PPHN)
- Point Comfort Underwriters
- Private Healthcare Systems (PHCS)
- UnitedHealthcare
- Veteran Affairs Community Care Network (Optum-VACCN)